TipRanks
Go Ultimate55% OFF

Newron Pharmaceuticals SpA (0QOI) Share Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

0QOI Analyst Ratings

Moderate Buy
2Ratings
2Buy0Hold0Sell
Based on 2 analysts giving stock ratings to Newron Pharmaceuticals SpA in the past 3 months

0QOI Stock 12 Month Forecast

CHF 24.50▲(173.13% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Newron Pharmaceuticals SpA in the last 3 months. The average price target is CHF 24.50 with a high forecast of CHF 30.00 and a low forecast of CHF 19.00. The average price target represents a 173.13% change from the last price of CHF 8.97.
Highest Price TargetCHF 30.00Average Price TargetCHF 24.50Lowest Price TargetCHF 19.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for GB:0QOI
Price TargetFollowArticle
H.C. WainwrightCHF 26→CHF 30buy234.45%UpsideReiterated10/22/26
Roth MKMCHF 19buy111.82%UpsideAssigned10/05/26
Lucid Capital―buy―Initiated12/11/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
MDWDMediwound
IMUXImmunic
RZLTRezolute
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Newron Pharmaceuticals SpA

3 Months
Ram Selvaraju
Ram SelvarajuH.C. Wainwright
Success Rate2/8 ratings generated profit
25%
Average Return
+28.40%

Copying Ram Selvaraju's trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of +28.40% per trade.

1 Year
Ram Selvaraju
Ram SelvarajuH.C. Wainwright
Success Rate3/8 ratings generated profit
38%
Average Return
+42.60%

Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of +42.60% per trade.

2 Years
Ram Selvaraju
Ram SelvarajuH.C. Wainwright
Success Rate3/8 ratings generated profit
38%
Average Return
+42.60%

Copying Ram Selvaraju's trades and holding each position for 2 Years would result in 37.50% of your transactions generating a profit, with an average return of +42.60% per trade.

0QOI Analyst Recommendation Trends

02468Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for 0QOI
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy45423
Buy00001
Hold00000
Sell00000
Strong Sell00000
total45424

In the current month, 0QOI has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0QOI average Analyst price target in the past 3 months is 24.50.

0QOI Financial Forecast

CHF -2CHF -1CHF 0CHF 1CHF 2Q2 2025Q2 2026Q4 2026
HighCHF -0.45
ConsensusCHF -0.71
LowCHF -0.94

0QOI Earnings Forecast

Next quarter’s earnings estimate for 0QOI is -CHF 0.71 with a range of -CHF 0.94 to -CHF 0.45. The previous quarter’s EPS was -CHF 0.74. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

CHF 2.9MCHF 13.5MCHF 24.1MCHF 34.7MCHF 45.3MQ2 2025Q2 2026Q4 2026
HighCHF 9.46M
ConsensusCHF 7.36M
LowCHF 4.64M

0QOI Sales Forecast

Next quarter’s sales forecast for 0QOI is CHF 7.36M with a range of CHF 4.64M to CHF 9.46M. The previous quarter’s sales results were CHF 2.93M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

0QOI Stock Forecast FAQ

What is GB:0QOI’s average 12-month price target, according to analysts?
Based on analyst ratings, Newron Pharmaceuticals SpA’s 12-month average price target is CHF24.50.
What is GB:0QOI’s upside potential, based on the analysts’ average price target?
Newron Pharmaceuticals SpA has 173.13% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Newron Pharmaceuticals SpA a Buy, Sell or Hold?
Newron Pharmaceuticals SpA has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Newron Pharmaceuticals SpA’s share price target?
The average share price target for Newron Pharmaceuticals SpA is CHF24.50. This is based on 2 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF30.00, and the lowest forecast is CHF19.00. The average share price target represents a 173.13% increase from the current price of CHF8.97.
What do analysts say about Newron Pharmaceuticals SpA?
Newron Pharmaceuticals SpA’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of Newron Pharmaceuticals SpA?
To buy shares of GB:0QOI, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.